Imai, M., Morizane, C., Hwang, W., Ohba, A., Kawamoto, Y., Komatsu, Y., Ueno, M., Kobayashi, S., Ikeda, M., Sasaki, M., Hiraoka, N., Yoshida, H., Kuchiba, A., Sadachi, R., Nakamura, K., Matsui, N., Ahn, C. H., Ock, C., Nakamura, Y., Yoshino, T. (2025). Membrane-specific HER2 expression by artificial intelligence-based quantitative scoring for prediction of efficacy of trastuzumab deruxtecan in biliary tract cancer (HERB trial): Exploratory analysis of a multicenter, single arm, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4097